These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34132367)

  • 1. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y; Liu S; Zhao T; Dang C
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
    Fan Y; Yu Y
    Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C; Ren Q; Deng J; Wang S; Ren L
    Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.
    Xu Y; Bao Y; Qiu G; Ye H; He M; Wei X
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
    Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.
    He G; Gu K; Wei J; Zhang J
    Thorac Cancer; 2024 Apr; 15(11):919-928. PubMed ID: 38462740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Wang H; Xu B; Shi J
    Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.
    Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y
    Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.
    Li M; Wang Q; Zhang X; Yan N; Li X
    Cell Cycle; 2021 Jul; 20(13):1279-1294. PubMed ID: 34097560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3-m6A methylation inhibits the proliferation and viability of type II alveolar epithelial cells in acute lung injury by enhancing the stability and translation efficiency of Pten mRNA.
    Wang Q; Shen J; Luo S; Yuan Z; Wei S; Li Q; Yang Q; Luo Y; Zhuang L
    Respir Res; 2024 Jul; 25(1):276. PubMed ID: 39010105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m
    Zhang R; Chen P; Wang Y; Zeng Z; Yang H; Li M; Liu X; Yu W; Hou P
    Int J Biol Sci; 2024; 20(12):4750-4766. PubMed ID: 39309428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer.
    Xu X; Zhang P; Huang Y; Shi W; Mao J; Ma N; Kong L; Guo L; Liu J; Chen J; Lu R
    Cancer Sci; 2023 Jan; 114(1):105-114. PubMed ID: 36114749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.